The goal of this study is to learn whether children, adolescents, and young adults with newly diagnosed high-grade osteosarcoma can be safely discharged from t…

Osteosarcoma in ChildrenOsteosarcoma in Adolescents and Young Adults

~Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT07560826

Phase 1

Study of Tegavivint, a Transducin Beta-like Protein 1 (TBL1) Inhibitor, With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

The goal of this clinical trial is to define the maximum tolerated dose (MTD) and/or Recommended phase 2 dose (RP2D) of Tegavivint in combination with Gemcitab…

Osteosarcoma RecurrentOsteosarcoma in ChildrenRelapsed Osteosarcoma+1 more

~Estimated

~$10 – $6,250

Emory UniversityNCT07144254